Home » Products » Modified Cyclodextrin » Sulfobutyl Ether-beta-cyclodextrin Sodium Salt;Betadex Sulfobutyl Ether Sodium;SBECD;

Product Category


Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Sulfobutyl Ether-beta-cyclodextrin Sodium Salt;Betadex Sulfobutyl Ether Sodium;SBECD;

Product Description
Product Name: Sulfobutyl Ether-beta-cyclodextrin Sodium Salt
Cas No: 182410-00-0

Sulfobutylated beta-cyclodextrin sodium salt;Sodium sulfobutylether β-cyclodextrin;Betadex Sulfobutyl Ether Sodium;sulfobutyl ether B-cyclodextrin;sodium salts;sulfobutyl ethers;SBECD;Excipient SBECD;

Structural Formula: buy Betadex Sulfobutyl Ether Sodium SBECD 182410-00-0
Molecular Formula: C42H70O35
Molecular Weight: 1134.9842
Pubchem SID 66577045
Technical Spec.:
Quality Index
White powder
>=99%; USP & EP standard
  1. SBE-β-CD(Cas No.:182410-00-0)is a high water-soluble anionic cyclodextrin derivative. It can easily form non-covalent inclusion complexes with drug molecules, thus it has the good performances in enhancing drug stability, solubility and safety, reducing drug toxicity and hemolysis, covering up bad smell, and controlling drug release rate.

  2. 2.SBE-β-CD(Cas No.:182410-00-0),as an excipient,has been used in injection, oral, nasal and eye medication. Modification by charged functional units can improve the binding affinity of cyclodextrins for oppositely charged guests, so it has a special affinity for drugs with nitrogen elements.

  3. 3.SBECD(Cas No.:182410-00-0) is used in the formulation as a solubilizing agent due to the limited aqueous solubility of remdesivir which can treat Covid-19.

Rm 1955,Building 2,No.215,Lianhe North Rd.,Fengxian Dist.Shanghai 201417 China
About Us
Tocosynth is the Chinese dosmetic susidiary company of Tocopharm,who mainly R&D and manufacturing chemicals raw materials based in Shanghai,China.Our company was established in 2012.
Sign up for our newsletter to receive the latest news.

Copryright © 2023 Tocopharm(Shanghai) Co., Ltd. Technology by Leadong.Sitemap